Ergofarma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 18,224 | 34,204 | 13,502 | 23,626 | 21,021 | 14,693 | 9,507 | 376 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -15,095 | -17,584 | -20,813 | 2,600 | -9,343 | -4,846 | -7,905 | -27,393 |
| Equity | 55,971 | 38,387 | 17,575 | 20,175 | 10,832 | 5,986 | -1,919 | -29,313 |
| Liabilities | 1,526 | 9,817 | 10,293 | 7,551 | 12,954 | 9,678 | 12,935 | 38,141 |
| Non-current assets | 0 | 12,165 | 2,707 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 57,497 | 36,039 | 25,161 | 27,726 | 23,738 | 15,652 | 11,016 | 8,828 |
| Total assets | 57,497 | 48,204 | 27,868 | 27,726 | 23,738 | 15,652 | 11,016 | 8,828 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 514 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +20.5% | +87.7% | -60.5% | +75.0% | -11.0% | -30.1% | -35.3% | -96.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -26.3% | -36.5% | -74.7% | 9.4% | -39.4% | -31.0% | -71.8% | -310.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -27.0% | -45.8% | -118.4% | 12.9% | -86.3% | -81.0% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -82.8% | -51.4% | -154.1% | 11.0% | -44.4% | -33.0% | -83.1% | -7285.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.3 | 0.6 | 0.4 | 1.2 | 1.6 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,224 | 34,204 | 13,502 | 23,626 | 21,021 | 14,693 | 9,507 | 376 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ergofarma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-20 | 2026-04-22 | 50.97 |
| 2025-11-18 | 2025-11-23 | 0.04 |
| 2025-10-23 | 2025-11-05 | 0.04 |
| 2025-08-28 | 2025-08-29 | 23.26 |
| 2025-08-19 | 2025-08-24 | 23.26 |
| 2024-07-16 | 2024-07-16 | 46.11 |
| 2023-12-18 | 2023-12-20 | 0.30 |
| 2023-11-16 | 2023-12-10 | 0.30 |
| 2023-10-25 | 2023-11-08 | 0.30 |
| 2023-07-18 | 2023-07-30 | 53.39 |
| 2022-09-16 | 2022-09-19 | 0.04 |
| 2022-08-23 | 2022-09-04 | 0.04 |
Ergofarma - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.